Filter Results
:
(679)
Show Results For
-
All HBS Web
(993)
- News (152)
- Research (679)
- Events (23)
- Multimedia (1)
- Faculty Publications (429)
Show Results For
-
All HBS Web
(993)
- News (152)
- Research (679)
- Events (23)
- Multimedia (1)
- Faculty Publications (429)
←
Page 34 of
679
Results
Sort by
- 12 Jul 2016
- First Look
July 12, 2016
spending. Whereas traditional (small-molecule) drugs have historically faced price competition from generic drugs after patent expiration, biosimilars—biologic drugs that have been shown to be therapeutically equivalent to an already...
View Details
Keywords:
Sean Silverthorne
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and testing. With health benefits globally from the availability of new drugs, albeit for poorer...
View Details
Keywords:
Sean Silverthorne
- 31 Jan 2017
- Research & Ideas
Why These Business School Professors Oppose Trump's Executive Order on Immigration
engineering, technology and mathematics (STEM), and they have equivalent contributions in outcomes like granted patents and entrepreneurial firm starts. These contributions are increasing, up from 10%-15% just a couple of decades ago. And...
View Details
Keywords:
by Staff
- 02 Feb 2010
- First Look
First Look: Feb. 2
million patented inventions supports these arguments: Individuals working alone, especially those without affiliation to organizations, are less likely to achieve breakthroughs and more likely to invent particularly poor outcomes....
View Details
Keywords:
Martha Lagace
- ←
- 34